Disposable electrochemical detection of breast cancer tumour marker CA 15-3 using poly(Toluidine Blue) as imprinted polymer receptor

被引:92
|
作者
Ribeiro, J. A. [1 ,2 ]
Pereira, C. M. [1 ]
Silva, A. F. [1 ]
Sales, M. Goreti F. [2 ]
机构
[1] Univ Porto, Fac Sci, Dept Chem & Biochem, CIQUP, Porto, Portugal
[2] Polytech Inst Porto, Sch Engn, BioMark CINTESIS ISEP, Porto, Portugal
来源
基金
欧洲研究理事会;
关键词
Biosensor; Carbohydrate antigen 15-3; Toluidine Blue; Screen-printed gold electrode; Molecularly-imprinted polymer; HORSERADISH-PEROXIDASE; SIGNAL AMPLIFICATION; MODIFIED ELECTRODE; HYDROGEN-PEROXIDE; AMPEROMETRIC BIOSENSORS; CARDIAC BIOMARKER; ANTIGEN CA15-3; IMMUNOSENSOR; GRAPHENE; SURFACE;
D O I
10.1016/j.bios.2018.03.011
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
In this work, electrically-conducting poly(Toludine Blue) was employed for the first time as synthetic receptor film, prepared by Molecular Imprinting strategies and using electrochemical methods, for the specific screening of breast cancer biomarker Carbohydrate Antigen 15.3 (CA 15-3). The protein imprinted poly(Toluidine Blue) film was grown in a pre-formed Toluidine Blue (TB) tailed SAM at the AuSPE surface, which greatly enhanced the stability against degradation of the Molecular Imprinted Polymer (MIP) film at the electrode surface. The MIP receptor film recognition ability towards the protein was investigated by fitting data to Freundlich isotherm. The binding affinity (K-p) obtained for the MIP system was significantly higher (similar to 12-fold) to that obtained for the NIP system, demonstrating the success of the approach in creating imprinted materials that specifically respond to CA 15-3 protein. The incubation of the MIP modified electrode with increasing concentration of protein (from 0.10 U mL(-1) to 1000 U mL(-1)) resulted in a decrease of the ferro/ferricyanide redox current. The device displayed linear response from 0.10 U mL(-1) to 100 U mL(-1) and LODs below 0.10 U mL(-1) were obtained from calibration curves built in neutral buffer and diluted artificial serum, using DPV technique, enabling the detection of the protein biomarker at clinically relevant levels. The developed MIP biosensor was applied to the determination of CA 15-3 in spiked serum samples with satisfactory results. The developed device provides a new strategy for sensitive, rapid, simple and cost-effective screening of CA 15-3 biomarker. Importantly, the overall approach seems suitable for point-of-care (PoC) use in clinical context.
引用
收藏
页码:246 / 254
页数:9
相关论文
共 50 条
  • [21] The prognostic value of the tumor marker CA 15-3 at initial diagnosis of patients with breast cancer
    McLaughlin, R
    McGrath, J
    Grimes, H
    Given, HF
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (04): : 340 - 342
  • [22] CEA and early detection of relapse in breast cancer subtypes: Comparison with CA 15-3
    Riedinger, Jean-Marc
    Goussot, Vincent
    Desmoulins, Isabelle
    Lorgis, Veronique
    Coutant, Charles
    Beltjens, Francoise
    Lizard, Sarab
    Fumoleau, Pierre
    BULLETIN DU CANCER, 2016, 103 (05) : 434 - 443
  • [23] Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer
    Eskelinen, M
    Kataja, V
    Hamalainen, E
    Kosma, VM
    Penttila, I
    Alhava, E
    ANTICANCER RESEARCH, 1997, 17 (2B) : 1231 - 1234
  • [24] Tumour markers CEA and CA 15-3 as prognostic factors in breast cancer - Univariate and multivariate analysis
    Ebeling, FC
    Schmitt, UM
    Untch, M
    Nagel, D
    Fateh-Moghadam, A
    Stieber, P
    Seidel, D
    ANTICANCER RESEARCH, 1999, 19 (4A) : 2545 - 2550
  • [25] The usefulness of the tumor marker CA 15-3 and TPA for the early diagnosis of bone metastses in the breast cancer
    Papadogeorgopoulos, Christos
    ANNALS OF ONCOLOGY, 2004, 15 : 58 - 58
  • [26] Breast cancer detection based on cancer antigen 15-3; emphasis on optical and electrochemical methods: A review
    Pourmadadi, Mehrab
    Ghaemi, Amirhossein
    Khanizadeh, Amirhossein
    Yazdian, Fatemeh
    Mollajavadi, Yasin
    Arshad, Rabia
    Rahdar, Abbas
    BIOSENSORS & BIOELECTRONICS, 2024, 260
  • [27] Clinical value of CA 15-3 for detection of distant metastases in newly diagnosed breast cancer
    Gonssaud, Barbara
    Goussot, Vincent
    Berriolo-Riedinger, Alina
    Saitta-Aribau, Emeline
    Coutant, Charles
    Cochet, Alexandre
    Fumoleau, Pierre
    Riedinger, Jean-Marc
    ANNALES DE BIOLOGIE CLINIQUE, 2017, 75 (04) : 421 - 429
  • [28] Clinical value of CA 15-3 for early detection of relapse in locally advanced breast cancer
    Konan, Stephane
    Goussot, Vincent
    Desmoulins, Isabelle
    Lorgis, Veronique
    Coutant, Charles
    Fumoleau, Pierre
    Beltjens, Francoise
    Dalban, Cecile
    Lizard, Sarab
    Riedinger, Jean-Marc
    BULLETIN DU CANCER, 2015, 102 (10) : 834 - 844
  • [29] The relation between tumor marker Ca 15-3 and metastases in interpectoral lymph nodes in breast cancer patients
    Vrdoljak, DV
    Knezevic, F
    Ramljak, V
    SAUDI MEDICAL JOURNAL, 2006, 27 (04) : 460 - 462
  • [30] Value of CA 15-3 detection in cerebrospinal fluid (CSF) of breast cancer leptomeningeal metastases.
    Salingue, S.
    Girot, M.
    Rodrigues, I.
    Taillibert, S.
    Kotecki, N.
    Zairi, F.
    Baranzelli, M.
    Faivre-Pierret, M.
    Devos, P.
    Bonneterre, J.
    Dubois, F.
    Le Rhun, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)